Latest Press Releases | MSF Access

Latest Press Releases

Civil society demonstration against IP provisions in RCEP that can block access to affordable medicines. Outside Ministry of Commerce, Udyog Bhawan, New Delhi

Photograph by Siddharth Singh

Press release |

08 May 2017

Intellectual property and trade

IndiaPhilippines

MSF response on RCEP negotiations in the Philippines

4 min

In New York, on Word Pneumonia Day 2015 (Nov 12), MSF volunteers attempted to deliver more than $17 million of fake cash - the equivalent of one day of profits from the pneumonia vaccines for Pfizer globally - to Pfizer's CEO Ian Read. The same day, MSF launched a global petition to ask Pfizer and GlaxoSmithKline (GSK) to reduce the price of the pneumococcal vaccine to $5 dollars per child (for all three doses) in developing countries. Credit: Edwin Torres.

Photograph by Edwin Torres

Press release |

27 April 2017

Vaccines

Investors join MSF in calling Pfizer to reduce the price of vaccine against top childhood killer

A coolbox full of vaccines for the massive MSF multi antigen campaign in Bangassou sub-prefecture, Mbomou prefecture, CAR. Photograph by Sandra Smiley

Photograph by Sandra Smiley

Press release

Press release |

26 April 2017

Vaccines

Study: Replacing existing vaccines with heat-stable versions saves money, protects more mothers and children from deadly diseases

5 min

Vials of PCV13, a vaccine that protects children against pneumonia and meningitis. At 9 Euros a dose (three doses are necessary for the vaccine to be effective) PCV13 is currently priced at a rate much higher than most people in Central African Republic can afford. Photograph by Sandra Smiley

Photograph by Sandra Smiley

Press release |

25 April 2017

US Department of Defense announces decision to give pharmaceutical corporation exclusive rights on taxpayer-funded Zika vaccine

First set of free Hepatitis C medicines Sofosbuvir and Daclatasvir provided by Delhi Govt. run GB Pant hospital. Photograph by Garvit Nangia

Photograph by Garvit Nangia

Press release |

31 March 2017

Intellectual property and trade

Brazil

Scale up of hepatitis C treatment possible as Brazil rejects patent on key drug

5 min

MSF Pharmacy Technician Toueng Sreymon distributes Hepatitis C meds at the MSF Hepatitis C clinic at Preah Kossamak Hospital in Phnom Penh, Cambodia, 18, April 2017. Photograph by Todd Brown

Photograph by Todd Brown

Press release |

27 March 2017

MSF joins Europe-wide action challenging patent on key hepatitis C drug

Bacteria culture tubes for BACTEC™ MGIT™ 960 Mycobacterial detection system in the National TB Reference Laboratory. This device helps growing and detecting TB bacteria and determining drug resistances. Government Hospital, Mbabane, Swaziland. Photograph by Alexis Huguet

Photograph by Alexis Huguet

Press release

Press release |

24 March 2017

MSF urges pharma firms to release clinical data on TB drug

3 min

Eight-week-old Mohamed Zakari receives his first dose of the oral rotavirus vaccine (or the placebo). Eight weeks is the cut-off age. If Hadiza had come one day later, they would have had to be excluded from the clinical trial in order to comply with the medical protocol. Mohamed will receive the second and third doses of the vaccine at 10 and 14 weeks, respectively. Photograph by Séverine Bonnet

Photograph by Séverine Bonnet

Press release

Press release |

23 March 2017

Vaccines

Innovative vaccine could prevent thousands of child deaths from diarrhoea

3 min